242 related articles for article (PubMed ID: 15934100)
21. Relationship between interleukin 6 promoter polymorphism at position -174, IL-6 serum levels, and the risk of relapse/recurrence in polymyalgia rheumatica.
Boiardi L; Casali B; Farnetti E; Pipitone N; Nicoli D; Cantini F; Macchioni P; Bajocchi G; Catanoso MG; Pulsatelli L; Consonni D; Salvarani C
J Rheumatol; 2006 Apr; 33(4):703-8. PubMed ID: 16583473
[TBL] [Abstract][Full Text] [Related]
22. Contemporary prevalence estimates for giant cell arteritis and polymyalgia rheumatica, 2015.
Crowson CS; Matteson EL
Semin Arthritis Rheum; 2017 Oct; 47(2):253-256. PubMed ID: 28551169
[TBL] [Abstract][Full Text] [Related]
23. Interruptions in rheumatology subspecialty care among patients with rheumatoid arthritis.
Ward MM; Rao R
J Rheumatol; 1995 Dec; 22(12):2319-26. PubMed ID: 8835569
[TBL] [Abstract][Full Text] [Related]
24. Progression of functional disability in patients with rheumatoid arthritis. Associations with rheumatology subspecialty care.
Ward MM; Leigh JP; Fries JF
Arch Intern Med; 1993 Oct; 153(19):2229-37. PubMed ID: 8215726
[TBL] [Abstract][Full Text] [Related]
25. Polymyalgia rheumatica with low erythrocyte sedimentation rate at diagnosis.
Proven A; Gabriel SE; O'Fallon WM; Hunder GG
J Rheumatol; 1999 Jun; 26(6):1333-7. PubMed ID: 10381052
[TBL] [Abstract][Full Text] [Related]
26. Lack of association between infection and onset of polymyalgia rheumatica.
Narváez J; Clavaguera MT; Nolla-Solé JM; Valverde-Garcia J; Roig-Escofet D
J Rheumatol; 2000 Apr; 27(4):953-7. PubMed ID: 10782822
[TBL] [Abstract][Full Text] [Related]
27. A disease activity score for polymyalgia rheumatica.
Leeb BF; Bird HA
Ann Rheum Dis; 2004 Oct; 63(10):1279-83. PubMed ID: 15361387
[TBL] [Abstract][Full Text] [Related]
28. Sex differences in temporal arteritis and polymyalgia rheumatica.
Narvaez J; Nolla-Solé JM; Valverde-García J; Roig-Escofet D
J Rheumatol; 2002 Feb; 29(2):321-5. PubMed ID: 11838850
[TBL] [Abstract][Full Text] [Related]
29. The widening mortality gap between rheumatoid arthritis patients and the general population.
Gonzalez A; Maradit Kremers H; Crowson CS; Nicola PJ; Davis JM; Therneau TM; Roger VL; Gabriel SE
Arthritis Rheum; 2007 Nov; 56(11):3583-7. PubMed ID: 17968923
[TBL] [Abstract][Full Text] [Related]
30. [Follow-up studies in polymyalgia rheumatica and temporal arteritis].
Li J; Tang FL; Wang XD; Yu JH
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Dec; 24(6):643-5. PubMed ID: 12905697
[TBL] [Abstract][Full Text] [Related]
31. Glucocorticoids and cardiovascular and cerebrovascular events in polymyalgia rheumatica.
Maradit Kremers H; Reinalda MS; Crowson CS; Davis JM; Hunder GG; Gabriel SE
Arthritis Rheum; 2007 Mar; 57(2):279-86. PubMed ID: 17330277
[TBL] [Abstract][Full Text] [Related]
32. Validity of the polymyalgia rheumatica activity score in primary care practice.
Binard A; Lefebvre B; De Bandt M; Berthelot JM; Saraux A;
Ann Rheum Dis; 2009 Apr; 68(4):541-5. PubMed ID: 18477738
[TBL] [Abstract][Full Text] [Related]
33. Giant cell arteritis and polymyalgia rheumatica: usefulness of vascular magnetic resonance imaging studies in the diagnosis of aortitis.
Narváez J; Narváez JA; Nolla JM; Sirvent E; Reina D; Valverde J
Rheumatology (Oxford); 2005 Apr; 44(4):479-83. PubMed ID: 15716321
[TBL] [Abstract][Full Text] [Related]
34. Sex differences in giant cell arteritis.
Nir-Paz R; Gross A; Chajek-Shaul T
J Rheumatol; 2002 Jun; 29(6):1219-23. PubMed ID: 12064839
[TBL] [Abstract][Full Text] [Related]
35. [Polymyalgia rheumatica and giant cell arteritis: recent data and current situation].
Announ N; Guerne PA
Rev Med Suisse; 2008 Mar; 4(149):696-8, 701. PubMed ID: 18472729
[TBL] [Abstract][Full Text] [Related]
36. Reappraisal of the epidemiology of giant cell arteritis in Olmsted County, Minnesota, over a fifty-year period.
Salvarani C; Crowson CS; O'Fallon WM; Hunder GG; Gabriel SE
Arthritis Rheum; 2004 Apr; 51(2):264-8. PubMed ID: 15077270
[TBL] [Abstract][Full Text] [Related]
37. Diagnosing late onset rheumatoid arthritis, polymyalgia rheumatica, and temporal arteritis in patients presenting with polymyalgic symptoms. A prospective longterm evaluation.
Pease CT; Haugeberg G; Morgan AW; Montague B; Hensor EM; Bhakta BB
J Rheumatol; 2005 Jun; 32(6):1043-6. PubMed ID: 15940765
[TBL] [Abstract][Full Text] [Related]
38. Genetic markers of disease susceptibility and severity in giant cell arteritis and polymyalgia rheumatica.
González-Gay MA; Amoli MM; Garcia-Porrua C; Ollier WE
Semin Arthritis Rheum; 2003 Aug; 33(1):38-48. PubMed ID: 12920695
[TBL] [Abstract][Full Text] [Related]
39. [Polymyalgia rheumatica and temporal arteritis].
Vos PA; Bijlsma JW; Derksen RH
Ned Tijdschr Geneeskd; 2005 Aug; 149(35):1932-7. PubMed ID: 16159030
[TBL] [Abstract][Full Text] [Related]
40. Relationship between patient age and duration of physician visit in ambulatory setting: does one size fit all?
Lo A; Ryder K; Shorr RI
J Am Geriatr Soc; 2005 Jul; 53(7):1162-7. PubMed ID: 16108934
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
